Lung Cancers Completed Phase 2 Trials for Cixutumumab (DB12250)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01263782BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung CancerTreatment